PAA Financials: Results, Ratios & Statements | Pharmaust | Shorted

⌘K

PAA

Pharmaceuticals, Biotechnology & Life Sciences

Pharmaust

Short interest: 0.02%; −0.02 pp 30d; as of 14 Oct 2024
Reported shorts: 108.1K
Shares on issue: 486.635M

Fundamentals

Our data providers hold no financial statements for PAA (last checked 15 Oct 2026). The company's own filings are listed below.

Financial reports

The company's own filings, newest first

Appendix 4C & Quarterly Update
Quarterly Report31 Jul 2026via asx_announcements
Appendix 4C & Quarterly Update
Quarterly Report30 Apr 2026via asx_announcements
Appendix 4D - Half-year Financial Report - 31 December 2025
Half Year Results25 Feb 2026via asx_announcements
Appendix 4C & Quarterly Update
Quarterly Report30 Jan 2026via asx_announcements
Appendix 4C & Quarterly Update
Quarterly Report29 Oct 2025via asx_announcements
Appendix 4E and 2025 Annual Report
Annual Results26 Aug 2025via asx_announcements
Appendix 4C & Quarterly Update
Quarterly Report30 Jul 2025via asx_announcements
Appendix 4C & Quarterly Update
Quarterly Report28 Apr 2025via asx_announcements
Appendix 4D - Half-year Financial Report - 31 December 2024
Half Year Results17 Feb 2025via asx_announcements
Appendix 4C & Quarterly Update
Quarterly Report29 Jan 2025via asx_announcements

Showing 10 of 81 reports